and grants/research support from Hanmi Pharmaceutical Co., Janssen Pharmaceuticals, Inc., Metavention, Novo Nordisk, Poxel SA, and Sanofi
Tirzepatide (Mounjaro): Commence with 5 mg subcutaneously once weekly, with subsequent weekly titration up to 15 mg or 20 mg, depending on patient response and tolerability
Remove the needle and dispose of it properly in a sharps container
Additionally, GLP-1RAs therapy increases circulating vascular progenitor cell content while reducing proinflammatory granulocyte precursor levels, representing an additional mechanism underlying their cardioprotective effects (96)
This is a common and legal path, especially during periods of national drug shortages or when branded medications are cost-prohibitive
Their glucose-dependent mechanism limits the risk for hypoglycemia, and they are associated with weight loss